SMS Pharmaceuticals Share Price
Small Cap | Pharmaceuticals and health care | NSE: SMSPHARMA | BSE: 532815
₹209.77 
-18.24 (-8.00 %)
Last Updated: 04 Apr 2025 03:48 PM
BULLISH
Overview
Open (₹) 228.99
High (₹) 228.99
Low (₹) 206.87
Prev. Close (₹) 228.01
Volume 2,02,457
VWAP (₹) 194.01
ROCE (%) 12.75
Industry P/E 44.73
TTM P/E 28.12
P/B Ratio 3.31
Market Cap (₹) Cr.1,859.65
Dividend Yield (%)0.19
EPS (₹) 5.89
ROE9.30%
Sales Growth (%) 35.86
Profit Growth (%)1,166.70
Day Range
228.99228.99
52 Week Range
176.00398.00
Historical Returns
Returns (6M)
-37.92 %
Returns (1Y)
1.76 %
Returns (3Y)
102.19 %
Returns (5Y)
578.87 %
Returns (6M)
-37.92 %
Returns (1Y)
1.76 %
Returns (3Y)
102.19 %
Returns (5Y)
578.87 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Efficient in managing Assets to generate Profits - ROA improved since last year
- Increasing Annual Revenue for Past 2 Years
- Growth in Net Profit Margin (QoQ)
- Growth in Annual Net Profit with increasing Profit Margin (YoY)
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Price above the pivot point indicates bullish sentiment.
Technicals
Technical Rating
BULLISHRSI 60.47
MFI 40.32
ATR 13.64
Commodity Channel Index -99.49
ROC125 -43.62
ROC21 -4.07
Williams %R -75.65
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 196.92 | 201.95 | 204.91 | 193.96 | 188.93 | 185.97 | 180.94 |
| Week Ago | 225.66 | 236.83 | 248.66 | 213.83 | 202.66 | 190.83 | 179.66 |
| Month Ago | 197.34 | 205.26 | 212.43 | 190.17 | 182.25 | 175.08 | 167.16 |
EMA & SMA
209.77
Current Price
Bullish Moving Averages
14
Bearish Moving Averages
6
5 Day 207.66
9 Day 198.34
10 Day 199.23
12 Day 200.68
14 Day 202.78
20 Day 204.28
26 Day 202.90
50 Day 217.70
100 Day 252.90
200 Day 263.18
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 11 Sept, 2024 | ₹378.38 | 6,58,134 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 11 Sept, 2024 | ₹377.83 | 6,58,134 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 06 Mar, 2024 | ₹184.85 | 5,44,383 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 06 Mar, 2024 | ₹184.86 | 5,44,383 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 05 Mar, 2024 | ₹175.75 | 5,91,169 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 05 Mar, 2024 | ₹175.72 | 5,91,169 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 04 Mar, 2024 | ₹164.20 | 5,17,107 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Buy | 04 Mar, 2024 | ₹163.97 | 5,17,107 | NSE |
| GRAVITON RESEARCH CAPITAL LLP | bulk | Sell | 12 Feb, 2024 | ₹154.49 | 4,92,358 | NSE |
| DOVETAIL INDIA FUND CLASS 11 SHARES | bulk | Sell | 12 Feb, 2024 | ₹152.45 | 5,00,000 | NSE |
| ANNAPURNA TALLURI | block | Sell | 08 Dec, 2020 | ₹94.70 | 28,58,580 | NSE |
| RAMESH BABU POTLURI | block | Buy | 08 Dec, 2020 | ₹94.70 | 14,68,100 | NSE |
| HIMA BINDU POTLURI | block | Buy | 08 Dec, 2020 | ₹94.70 | 13,90,480 | NSE |
| VEERAVENKATA SATYANARAYANA MURTHY TALLURI | block | Sell | 07 Dec, 2020 | ₹94.70 | 42,24,680 | NSE |
| TALLURI VEERAVENKATA SATYANARAYANA MURTHY | block | Sell | 25 Nov, 2020 | ₹82.40 | 27,95,000 | NSE |
| VAMSI KRISHNA POTLURI | block | Buy | 25 Nov, 2020 | ₹82.40 | 27,95,000 | NSE |
| VEERAVENKATA SATYANARAYANA MURTHY TALLURI | block | Sell | 06 Mar, 2020 | ₹36.25 | 27,60,000 | NSE |
| VAMSI KRISHNA POTLURI | block | Buy | 06 Mar, 2020 | ₹36.25 | 27,60,000 | NSE |
Insider Trading
| Date | Name | Action | Avg. Price | Quantity | Deal Value |
|---|---|---|---|---|---|
| 31 Mar, 2025 | Potluri Infra Projects LLP | Acquisition | ₹95.25 | 15,00,000 | NSE |
| 31 Mar, 2025 | Ramesh Babu Potluri | Acquisition | ₹95.25 | 25,00,000 | NSE |
| 29 Mar, 2025 | Potluri Infra Projects LLP | Acquisition | ₹95.25 | 15,00,000 | NSE |
| 29 Mar, 2025 | Ramesh Babu Potluri | Acquisition | ₹95.25 | 25,00,000 | NSE |
| 29 Mar, 2025 | Potluri Laboratories Private Limited | Pledge | ₹227.65 | 11,20,320 | NSE |
| 29 Mar, 2025 | Potluri Infra Projects LLP | Pledge | ₹227.65 | 73,46,420 | NSE |
| 29 Mar, 2025 | Hima Bindu Potluri | Pledge | ₹227.65 | 30,00,000 | NSE |
| 30 Mar, 2024 | Neelima Potluru | Disposal | ₹182.26 | 18,850 | NSE |
| 29 Mar, 2024 | P Seeta Rama Brahmam | Disposal | ₹182.87 | 89,800 | NSE |
| 29 Mar, 2024 | TVT INFRACON LLP | Acquisition | ₹183.54 | 80,000 | NSE |
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 29 May, 2024 | Rs.0.4000 per share(40%)Final Dividend | 23 Sept, 2024 | 23 Sept, 2024 |
| 24 May, 2023 | Rs.0.3000 per share(30%)Final Dividend | 22 Sept, 2023 | 22 Sept, 2023 |
| 30 May, 2022 | Rs.0.3000 per share(30%)Final Dividend | 22 Sept, 2022 | 23 Sept, 2022 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 01 Apr, 2025 | BSE India | The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 28, 2025 for Hima Bindu Potluri |
| 01 Apr, 2025 | BSE India | The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 28, 2025 for Potluri Laboratories Pvt Ltd |
| 01 Apr, 2025 | BSE India | The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 28, 2025 for Potluri Infra Projects LLP |
| 31 Mar, 2025 | NSE India | SMS Pharmaceuticals Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015 |
| 31 Mar, 2025 | NSE India | SMS PHARMACEUTICALS LIMITED has informed the Exchange about Closure of Trading Window |
| 28 Mar, 2025 | BSE India | The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 27, 2025 for Potluri Infra Projects LLP |
| 28 Mar, 2025 | BSE India | The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 27, 2025 for Potluri Laboratories Pvt Ltd |
| 28 Mar, 2025 | BSE India | The Exchange has received the Disclosures of reasons for encumbrance by promoter of listed companies under Reg. 31(1) read with Regulation 28(3) of SEBI (SAST) Regulations, 2011 on March 27, 2025 for Hima Bindu Potluri |
| 27 Mar, 2025 | NSE India | SMS PHARMACEUTICALS LIMITED has informed the Exchange regarding Allotment of Securities |
| 27 Mar, 2025 | NSE India | SMS Pharmaceuticals Limited has informed the Exchange regarding ''Allotment of Equity Shares pursuant to exercise of Warrants allotted on preferential basis''. |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results & Others | To consider other business matters. | 07 Feb, 2025 | 12 Feb, 2025 |
| Quarterly Results | -- | 05 Nov, 2024 | 08 Nov, 2024 |
| Quarterly Results | -- | 30 Jul, 2024 | 05 Aug, 2024 |
| Audited Results & Final Dividend | -- | 23 May, 2024 | 29 May, 2024 |
| Quarterly Results & Preferential issue | -- | 07 Feb, 2024 | 08 Feb, 2024 |
| Quarterly Results | -- | 02 Nov, 2023 | 08 Nov, 2023 |
| Quarterly Results | -- | 03 Aug, 2023 | 08 Aug, 2023 |
| Audited Results & Final Dividend | -- | 18 May, 2023 | 24 May, 2023 |
| Quarterly Results | -- | 01 Feb, 2023 | 09 Feb, 2023 |
| Quarterly Results | -- | 09 Nov, 2022 | 12 Nov, 2022 |
Share Holding Pattern
| Owner Name | Mar, 2025 | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 |
|---|---|---|---|---|---|
| Promoter Group | 66.26% | 64.67% | 64.32% | 64.17% | 67.29% |
| Foreign Institutions + | 0.08% | 0.31% | 0.59% | 0.59% | 0.65% |
| Domestic Institutions + | 2.43% | 2.55% | 0% | 0% | 0% |
| Government | 0% | 0% | 0% | 0% | 0% |
| Public | 31.23% | 32.47% | 35.09% | 35.24% | 32.06% |
| Others | 0% | 0% | 0% | 0% | 0% |
About SMS Pharmaceuticals
SMS Pharmaceuticals is a Public Limited Listed company incorporated on 14/12/1987 and has its registered office in the State of Telangana, India. Company’s Corporate Identification Number(CIN) is L24239TG1987PLC008066 and registration number is 008066. Currently Company is involved in the business activities of Manufacture of medicinal substances used in the manufacture of pharmaceuticals: antibiotics, endocrine products, basic vitamins; opium derivatives; sulpha drugs; serums and plasmas; salicylic acid, its salts and esters; glycosides and vegetable alkaloids; chemically pure suger etc.. Company’s Total Operating Revenue is Rs. 709.26 Cr. and Equity Capital is Rs. 8.47 Cr. for the Year ended 31/03/2024. Read More
Parent Organisation
Not Applicable
Founded
1987
Managing Director
Mr. Ramesh Babu Potluri
NSE Symbol
SMSPHARMA
SMS Pharmaceuticals Management
| Name | Designation |
|---|---|
| Mr. Ramesh Babu Potluri | Chairman & Managing Director |
| Mr. Vamsi Krishna Potluri | Executive Director |
| Mr. Sarath Kumar Pakalapati | Independent Director |
| Mr. Sharvan Kudaravalli | Independent Director |
| Mr. Sarvepalli Srinivas | Independent Director |
| Dr.(Mrs.) Neelaveni Thummala | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on SMS Pharmaceuticals
What is the share price of SMS Pharmaceuticals?
The share price of SMS Pharmaceuticals on 04 Apr, 2025 is ₹ 209.77.
What is 52W high and 52W low share price of SMS Pharmaceuticals?
The highest and lowest 52W share prices of SMS Pharmaceuticals are ₹ 398.000 and ₹ 176.000
What is the market cap of SMS Pharmaceuticals?
The market capitalization of SMS Pharmaceuticals as of 04 Apr, 2025 is ₹ 1,859.65 Crores
What is the P/E ratio of SMS Pharmaceuticals?
The current P/E ratio of SMS Pharmaceuticals as of 04 Apr, 2025 is 44.73
What is the PB ratio of SMS Pharmaceuticals?
The PB ratio of SMS Pharmaceuticals as of 04 Apr, 2025 is 3.31
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)